Wang Dong, Huang Kai, Guo Shu-Zhen
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine Beijing 102488, China.
Zhongguo Zhong Yao Za Zhi. 2022 Jan;47(1):18-23. doi: 10.19540/j.cnki.cjcmm.20210917.703.
Cardiotoxicity is smong the main safety problems of drugs in clinical application. In recent years, traditional Chinese medicine has been gradually emphasized and studies on the evaluation of cardiac safety and prevention of cardiotoxicity of Chinese medicine have been on the rise, particularly the cardiotoxic Chinese medicine or the Chinese medicine components targeting cardiotoxicity. As for the research methods for cardiac safety evaluation of Chinese medicine, this review introduces the related clinical indexes and cell and animal models. As to the improvement of heart safety, this study reviews the material basis and mechanism of cardiotoxic Chinese medicines as well as the alleviation of cardiotoxicity by controlling the content of toxic compounds and changing dosage form, processing method, and compatibility of Chinese medicine. In addition, the effective components and mechanisms of prescriptions and active compounds in Chinese medicine for preventing and treating cardiotoxicity induced by chemotherapeutic drugs in recent years were summarized. This review is expected to serve as a reference for cardiac safety evaluation and clinical rational application of Chinese medicine.
心脏毒性是药物临床应用中的主要安全问题之一。近年来,中医药逐渐受到重视,对中药心脏安全性评价及心脏毒性防治的研究不断增加,尤其是对具有心脏毒性的中药或靶向心脏毒性的中药成分的研究。关于中药心脏安全性评价的研究方法,本综述介绍了相关临床指标以及细胞和动物模型。关于心脏安全性的改善,本研究综述了具有心脏毒性的中药的物质基础和作用机制,以及通过控制有毒化合物含量、改变剂型、炮制方法和中药配伍来减轻心脏毒性的方法。此外,还总结了近年来中药防治化疗药物所致心脏毒性的方剂及活性成分的有效成分和作用机制。本综述有望为中药的心脏安全性评价及临床合理应用提供参考。